nprnews_____ = ||| lubuntu at wor2 670N|||A New Type Of COVID-19 Vaccine Could Debut Soon||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Instead of putting genetic instructions into people whose cells then make a viral protein, the vaccines from Novavax, Medicago and Sanofi carry a spike protein payload.

-




class="imagewrap has-source-dimensions"
data-crop-type="wide"
style="
--source-width: 2280;
--source-height: 1283;
"
>




A New Type Of COVID-19 Vaccine Could Debut Soon







A vial of the experimental Novavax coronavirus vaccine is ready for use in a London study in 2020. Novavax's vaccine candidate contains a noninfectious bit of the virus — the spike protein — with a substance called an adjuvant added that helps the body generate a strong immune response.



Alastair Grant/AP


hide caption





toggle caption




Alastair Grant/AP













Shots - Health News




A New Type Of COVID-19 Vaccine Could Debut Soon



Instead of putting genetic instructions into people whose cells then make a viral protein, the vaccines from Novavax, Medicago and Sanofi carry a spike protein payload.